Emergence of drug resistance: implications for antiviral control of pandemic influenza

Murray E. Alexander, Christopher S Bowman, Zhilan Feng, Michael Gardam, Seyed M. Moghadas, Gergely Röst, Ping Yan

Proceedings of the Royal Society B Biological Sciences · 2007 · 93 citations · 29 references

DOIFull text

Open access

Concepts

TL;DR

The highly pathogenic H5N1 strain poses a pandemic threat, and while antiviral drugs are essential, the evolution of drug‑resistant mutants limits their effectiveness. The study develops a mathematical model to assess how antiviral treatment strategies influence the emergence of drug resistance and the containment of a pandemic. The model incorporates early treatment onset, population‑level coverage, and reproduction numbers to simulate the dynamics of wild‑type and resistant strains. The model shows that eliminating the wild‑type strain requires early, widespread treatment; a single‑strategy approach fails when the wild‑type reproduction number exceeds 1.4, and resistant strains can sustain an epidemic if their relative fitness exceeds 0.4, making uncontrolled pandemics likely without timely, strategic antiviral use.

Abstract

Given the danger of an unprecedented spread of the highly pathogenic avian influenza strain H5N1 in humans, and great challenges to the development of an effective influenza vaccine, antiviral drugs will probably play a pivotal role in combating a novel pandemic strain. A critical limitation to the use of these drugs is the evolution of highly transmissible drug-resistant viral mutants. Here, we develop a mathematical model to evaluate the potential impact of an antiviral treatment strategy on the emergence of drug resistance and containment of a pandemic. The results show that elimination of the wild-type strain depends crucially on both the early onset of treatment in indexed cases and population-level treatment. Given the probable delay of 0.5–1 day in seeking healthcare and therefore initiating therapy, the findings indicate that a single strategy of antiviral treatment will be unsuccessful at controlling the spread of disease if the reproduction number of the wild-type strain exceeds 1.4. We demonstrate the possible occurrence of a self-sustaining epidemic of resistant strain, in terms of its transmission fitness relative to the wild-type, and the reproduction number . Considering reproduction numbers estimated for the past three pandemics, the findings suggest that an uncontrollable pandemic is likely to occur if resistant viruses with relative transmission fitness above 0.4 emerge. While an antiviral strategy is crucial for containing a pandemic, its effectiveness depends critically on timely and strategic use of drugs.

References

29